Decreased SARS-CoV-2 viral load following vaccination

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592

Temporal dynamics in viral shedding and transmissibility of COVID-19

He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,300

A guide to vaccinology: from basic principles to new developments

Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593

Rethinking Covid-19 Test Sensitivity — A Strategy for Containment

Mina, M. J., Parker, R., & Larremore, D. B. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2025631 · Cited by 715

SARS-CoV-2 viral load predicts COVID-19 mortality

Pujadas, E., Chaudhry, F. F., McBride, R. B., Richter, F., Zhao, S., Wajnberg, A., Nadkarni, G. N., Glicksberg, B. S., Houldsworth, J., & Cordon‐Cardo, C. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30354-4 · Cited by 534

Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools

Yelin, I., Aharony, N., Tamar, E. S., Argoetti, A., Messer, E., Berenbaum, D., Shafran, E., Kuzli, A., Gandali, N., Shkedi, O., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa531 · Cited by 450

Understanding COVID-19 vaccine efficacy

Lipsitch, M., & Dean, N. E. (2020) · Science · doi:10.1126/science.abe5938 · Cited by 230

Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization

Chodick, G., Tene, L., Patalon, T., Gazit, S., Ben‐Tov, A., Cohen, D., & Muhsen, K. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.15985 · Cited by 189

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics Should Inform Policy

Çevik, M., Marcus, J. L., Buckee, C. O., & Smith, T. C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1442 · Cited by 141

SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn

Connors, M., Graham, B. S., Lane, H. C., & Fauci, A. S. (2021) · Annals of Internal Medicine · doi:10.7326/m21-0111 · Cited by 71

Insights into COVID-19 epidemiology and control from temporal changes in serial interval distributions in Hong Kong

Ali, S. T., Chen, D., Lau, Y. C., Lim, W. W., Yeung, A., Adam, D. C., Lau, E. H. Y., Wong, J. Y., Xiao, J., Ho, F. C. S., et al. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae220 · Cited by 6

Vaccination and testing of the border workforce for COVID-19 and risk of community outbreaks: a modelling study

Plank, M. J., Binny, R. N., Hendy, S. C., Lustig, A. G., & Ridings, K. (2021) · Royal Society Open Science · doi:10.1098/rsos.210686 · Cited by 6

COVID-19 vaccination in patients with cancer, a rapid review

Chehade, L., Zeitoun, J., Lombe, D. C., Irshad, S., Hemelrijck, M. V., Canfell, K., Sullivan, R. J., & Mukherji, D. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1355 · Cited by 6

BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19

Kaznadzey, A., Tutukina, M. N., Bessonova, T. A., Kireeva, M. L., & Mazo, I. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.797918 · Cited by 6

The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines

Rosen, B., Davidovitch, N., Chodick, G., & Israeli, A. (2022) · Israel Journal of Health Policy Research · doi:10.1186/s13584-022-00548-3 · Cited by 7

Efetividade das vacinas da COVID-19 e disseminação do vírus: revisão sistemática

de Medeiros, G. Q., de Barros, V. N., Guesser, V. M., de Paiva, K. M., & Haas, P. (2023) · Revista Neurociências · doi:10.34024/rnc.2023.v31.14806 · Cited by 8

A COVID‐19 cluster analysis in an office: Assessing the long‐range aerosol and fomite transmissions with infection control measures

Mizukoshi, A., Okumura, J., & Azuma, K. (2023) · Risk Analysis · doi:10.1111/risa.14249 · Cited by 6

Hyris bCUBE SARS-CoV-2 rapid molecular saliva testing: a POCT innovation on its way

Padoan, A., Cosma, C., Aita, A., Navaglia, F., Basso, D., Giannella, G., & Plebani, M. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0008 · Cited by 6

Effects of infection fatality ratio and social contact matrices on vaccine prioritization strategies

Schulenburg, A., Cota, W., Costa, G. S., & Ferreira, S. C. (2022) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0096532 · Cited by 5

Pneumonia Frequency and Severity in Patients With Symptomatic COVID-19: Impact of mRNA and Adenovirus Vector Vaccines

Vicini, S., Bellini, D., Iannarelli, A., Rengo, M., Pelle, G., Ruggiero, S., Fusco, M., Ambrogi, C., & Carbone, I. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.22.27843 · Cited by 6

Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection

Kang, S., Kim, J. Y., Park, H., Lim, S. Y., Kim, J., Bae, S., Jung, J., Kim, M. J., Chong, Y. P., Lee, S., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.06.002 · Cited by 6

Vacunación frente a la neumonía adquirida en la comunidad del adulto. Actualización 2021 del posicionamiento del Grupo de Neumoexpertos en Prevención

Redondo, E., Calle, I. R., Mascarós, E., Yuste, J., Fernández-Prada, M., Ocaña, D., Jimeno, I., Gil, A., Molina, J., Díaz-Maroto, J. L., et al. (2021) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2021.06.005 · Cited by 6

Vaccination Strategies for Minimizing Loss of Life in COVID-19 in a Europe Lacking VaccinesPreprint

Hunziker, P. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3780050 · Cited by 6

Payments and freedoms: Effects of monetary and legal incentives on COVID-19 vaccination intentions in GermanyPreprint

Sprengholz, P., Henkel, L., & Betsch, C. (2021) · doi:10.31234/osf.io/hfm43 · Cited by 6

Vaccination is Australia's most important COVID-19 public health action, even though herd immunity is unlikelyPreprint

McBryde, E. S., Meehan, M. T., Sziklay, J., Adekunle, A. I., Kuddus, M. A., Ogunlade, S. T., Jayasundara, P., Ragonnet, R. R., Trauer, J. M., & Cope, R. C. (2021) · medRxiv · doi:10.1101/2021.07.16.21260642 · Cited by 5

COVID-19: Azelastine nasal spray Reduces Virus-load In Nasal swabs (CARVIN). Early intervention with azelastine nasal sprays reduces viral load in SARS-CoV-2 infected patients. First report on a double-blind placebo-controlled phase II clinical trial.Preprint

Klußmann, J. P., Lehmann, C., Grosheva, M., Şahin, K., Nagy, E., Szijártó, V., Nagy, G., Konrat, R., Meiser, P., Flegel, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-864566/v1 · Cited by 6

Innovations in vaccine design: Computational tools and techniques

Nag, R., Srivastava, S., Rizvi, S., Ahmed, S., & Raza, S. T. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.015 · Cited by 7

Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status

Boschi, C., Aherfi, S., Houhamdi, L., Colson, P., Raoult, D., & Scola, B. L. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.2008776 · Cited by 5

Relationship between Toothpaste Dilution Ratio and Droplets Generated during Tooth-Brushing

Satou, R., Yamagishi, A., Takayanagi, A., Higuchi, T., Oyama, T., Suzuki, S., & Sugihara, N. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074157 · Cited by 5

Comparative Analysis of Age, Sex, and Viral Load in Outpatients during the Four Waves of SARS-CoV-2 in A Mexican Medium-Sized City

Covantes‐Rosales, C. E., Barajas-Carrillo, V. W., Girón‐Pérez, D. A., Toledo‐Ibarra, G. A., Díaz‐Reséndiz, K. J. G., Navidad-Murrieta, M. S., Ventura‐Ramón, G. H., Pulido-Muñoz, M. E., Mercado‐Salgado, U., Ojeda-Durán, A. J., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095719 · Cited by 5

A country-specific model of COVID-19 vaccination coverage needed for herd immunity in adult only or population wide vaccination programme

Goh, F. T., Chew, Y. Z., Tam, C. C., Yung, C. F., & Clapham, H. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100581 · Cited by 5

COVID-19 vaccine knowledge, attitudes, perceptions and uptake among healthcare workers of Pune district, Maharashtra

Bassi, S., Bahl, D., Thapliyal, N., Maity, H., Marathe, S. D., Prakshale, B., Shah, V. G., Salunke, S. R., & Arora, M. (2022) · Journal of Global Health Reports · doi:10.29392/001c.37242 · Cited by 5

Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden

Stoeckel, F., Stöckli, S., Phillips, J. B., Lyons, B. A., Mérola, V., Barnfield, M., Szewach, P., Thompson, J., & Reifler, J. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.08.009 · Cited by 5

The impacts of vaccination status and host factors during early infection on SARS-CoV-2 persistence: a retrospective single-center cohort study

Tian, X., Zhang, Y., Wang, W., Fang, F., Zhang, W., Zhu, Z., & Wan, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109534 · Cited by 5

Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination

Hara, M., Furue, T., Fukuoka, M., Iwanaga, K., Matsuishi, E., Miike, T., Sakamoto, Y., Mukai, N., Kinugasa, Y., Shigyo, M., et al. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2226575 · Cited by 5

“It’s Your Fault!”—Said the Vaccinated to the Unvaccinated. The Effect of COVID-19 Vaccination on Responsibility Attribution

Drążkowski, D., & Trepanowski, R. (2024) · SAGE Open · doi:10.1177/21582440241251471 · Cited by 5

Effect of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) mRNA vaccination in healthcare workers with high-risk coronavirus disease 2019 (COVID-19) exposure

Selby, L. M., Hewlett, A. L., Cawcutt, K. A., Wood, M. G., Balfour, T., Rupp, M. E., & Starlin, R. C. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.193 · Cited by 5

Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines

Brunner‐Ziegler, S., Spath, T., Kornek, G. V., König, F., Parschalk, B., Schnetzinger, M., Straßl, R. P., Savic, R., Foit, A., Resch, H., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.023 · Cited by 5

Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review

Akamine, C. M., & Sahly, H. M. E. (2021) · Translational research · doi:10.1016/j.trsl.2021.12.007 · Cited by 5

Role of population and test characteristics in antigen-based SARS-CoV-2 diagnosis, Czechia, August to November 2021

Kliegr, T., Jarkovský, J., Jiřincová, H., Kuchař, J., Karel, T., & Tachezy, R. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.33.2200070 · Cited by 5

Three Cases of COVID-19 Variant Delta With and Without Vaccination — Chengdu City, Sichuan Province, April–May, 2021

Chen, H., Mao, Y., Duan, Z., Wang, L., Cheng, Y., Dai, Y., Luo, H., Xie, W., Fan, S., Zhou, Y., et al. (2021) · China CDC Weekly · doi:10.46234/ccdcw2021.137 · Cited by 5

Cross-Sectional Assessment of SARS-CoV-2 Viral Load by Symptom Status in Massachusetts Congregate Living Facilities

Lennon, N. J., Bhattacharyya, R. P., Mina, M. J., Rehm, H. L., Hung, D. T., Smole, S., Woolley, A. E., Lander, E. S., & Gabriel, S. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab367 · Cited by 42

Open-source real-time quantitative RT-PCR-based on a RNA standard for the assessment of SARS-CoV-2 viral load

Comerlato, J., Comerlato, C. B., Sant’Anna, F. H., Bessel, M., Abreu, C. M., & Wendland, E. (2021) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760210237 · Cited by 5

Spatial Allocation of Scarce COVID-19 Vaccines *†‡Preprint

Castonguay, F. M., Blackwood, J. C., Howerton, E., Shea, K., Sims, C. B., & Sanchirico, J. N. (2020) · medRxiv · doi:10.1101/2020.12.18.20248439 · Cited by 5

When can we stop wearing masks? Agent-based modeling to identify when vaccine coverage makes nonpharmaceutical interventions for reducing SARS-CoV-2 infections redundant in indoor gatheringsPreprint

Farthing, T. S., & Lanzas, C. (2021) · medRxiv · doi:10.1101/2021.04.19.21255737 · Cited by 6

Unambiguous Linkage Between the Vaccination Coverage and the Spread of COVID-19: Geostatistical Evidence from the Slovak LAU 1 Regions

Bleha, B., & Ďurček, P. (2023) · Journal of Geovisualization and Spatial Analysis · doi:10.1007/s41651-023-00144-2 · Cited by 4

Molecular accuracy vs antigenic speed: SARS-CoV-2 testing strategies

Fajardo, Á., Perbolianachis, P., Ferreiro, I., Moreno, P., & Moratorio, G. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.12.006 · Cited by 4

Spatiotemporal Associations between Local Safety Level Index and COVID-19 Infection Risks across Capital Regions in South Korea

Lym, Y., Lym, H., Kim, K. K., & Kim, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020824 · Cited by 5

Serological Screening of Immunoglobulin G against SARS-CoV-2 Nucleocapsid and Spike Protein before and after Two Vaccine Doses among Healthcare Workers in Japan

Hiramoto, S., Miyashita, D., Kimura, T., Niwa, T., Uchida, A., Sano, M., Murata, M., Nagasawa, T., Tsunekawa, K., Aoki, T., et al. (2022) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.2022.j017 · Cited by 4

COVID-19 vaccine compliance in adolescents with attention-deficit/hyperactivity disorder

Zemer, V. S., Hoshen, M. B., Gerstein, M., Richenberg, Y., Jacobson, E., Grosu, R., Cohen, M., & Cohen, H. A. (2022) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174221116734 · Cited by 4

Epidemiological and Serological Analysis of a SARS-CoV-2 Outbreak in a Nursing Home: Impact of SARS-CoV-2 Vaccination and Enhanced Neutralizing Immunity Following Breakthrough Infection

Streibl, B. I., Lahne, H., Grahl, A., Agsten, P., Bichler, M., Büchl, C., Damzog, M., Eberle, U., Gärtner, S., Hobmaier, B., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10091809 · Cited by 4

Optimal spatial evaluation of a pro rata vaccine distribution rule for COVID-19

Castonguay, F. M., Blackwood, J. C., Howerton, E., Shea, K., Sims, C. B., & Sanchirico, J. N. (2023) · Scientific Reports · doi:10.1038/s41598-023-28697-8 · Cited by 4

Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights

de Rioja, V. L., Perramon‐Malavez, A., Alonso, S., Andrés, C., Antón, A., Bordoy, A. E., Cámara, J., Cardona, P.-J., Català, M., López, D., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1339267 · Cited by 4

How Fast Vaccination Can Control the COVID-19 Pandemic in Brazil?

Oliveira, R. S., Xavier, C. R., Vieira, V. D. F., Rocha, B. M., Reis, R. F., Quintela, B. D. M., Lobosco, M., & dos Santos, R. W. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-77964-1_38 · Cited by 4

A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany

Schwarzer, R., Freys, S. D., Neuwinger, N., Beikert, N., Eberspächer, B., Edelmann, A., Żuchowski, M., Slothouwer, I., Stein, A., Theil, K., et al. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.532 · Cited by 4

Lower SARS-CoV-2 viral shedding following COVID-19 vaccination among healthcare workers in Los Angeles, California

Adamson, P. C., Pfeffer, M. A., Arboleda, V. A., Garner, O. B., Maurice, A. D. S., von Bredow, B., Flint, J., Kruglyak, L., & Currier, J. S. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab526 · Cited by 4

Laboratory Diagnosis and Utilization for COVID-19

Kim, M., Kim, H. S., Bae, H. G., Huh, H. J., & Sung, H. (2021) · Korean Journal of Healthcare-Associated Infection Control and Prevention · doi:10.14192/kjicp.2021.26.2.47 · Cited by 4

Is the Increased Transmissibility of SARS-CoV-2 Variants Driven by within or Outside-Host Processes?

Arav, Y., Fattal, E., & Klausner, Z. (2022) · Mathematics · doi:10.3390/math10193422 · Cited by 5

Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics?

Focosi, D., Franchini, M., Pirofski, L., Maggi, F., & Casadevall, A. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2314 · Cited by 4

COVID-19 Spreading Dynamics in an Age-Structured Population with Selective Relaxation of Restrictions for Vaccinated Individuals : a Mathematical Modeling StudyPreprint

Shayak, B., Sharma, M., & Mishra, A. K. (2021) · medRxiv · doi:10.1101/2021.02.22.21252241 · Cited by 4

A SARS CoV-2 nucleocapsid vaccine protects against distal viral disseminationPreprint

Class, J., Dangi, T., Richner, J. M., & Penaloza‐MacMaster, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.26.440920 · Cited by 4

Insights into COVID-19 epidemiology and control from temporal changes in serial interval distributions in Hong KongPreprint

Ali, S. T., Chen, D., Lim, W. W., Yeung, A., Adam, D. C., Lau, Y. C., Lau, E. H. Y., Wong, J. Y., Xiao, J., Ho, F. C. S., et al. (2022) · medRxiv · doi:10.1101/2022.08.29.22279351 · Cited by 4

Emerging Wake-up Call before next Pandemics as Apart of Medicine and Technology: We terribly need Social and Healthcare Workers

Jankechova, M., Dubovcova, M., Murgová, A., Otrubova, J., Bednaříková, M., Gazova, Z., Konosova, H., Taziarova, M., Kozon, V., Olah, M., et al. (2021) · Clinical Social Work and Health Intervention · doi:10.22359/cswhi_12_3_14 · Cited by 3

How to Stop Contagion: Applying Network Science to Evaluate the Effectiveness of COVID-19 Vaccine Distribution Plans

Chyzh, O. V. (2023) · The Journal of Politics · doi:10.1086/726933 · Cited by 3

Estimating the time-varying effective reproduction number via Cycle Threshold-based Transformer

Zhang, X.-Y., Yu, L.-L., Wang, W.-Y., Sun, G., Lv, J., Zhou, T., & Liu, Q.-H. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012694 · Cited by 3

Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases

Kumari, B., Hajela, K., Ali, A., Sharma, A. K., Yadav, R. K., Ranjan, A., Nair, R., Bharti, S., Dipankar, S. P., Singh, P. K., et al. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01033-z · Cited by 3

COVID-19 in elderly: Correlations of viral load, clinical course, laboratory parameters, among patients vaccinated with CoronaVac

Altıntop, S. E., Ünalan-Altıntop, T., Cihangiroğlu, M., Onarer, P., Sezgin, F. M., Gözükara, M. G., GÖZÜKARA, B., & Zengin, E. (2022) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2022.01849 · Cited by 3

Global Policy to Reduce the Incidence of Infection Spreading in Non-Vaccinated Healthcare Workers: A Literature Review

Ferrari, C., Somma, G., Ippoliti, L., Magrini, A., Giampaolo, L. D., & Coppeta, L. (2022) · Vaccines · doi:10.3390/vaccines10122058 · Cited by 3

Ibero‐Panamerican Federation of Periodontology Delphi study on the trends of periodontology and periodontics by the year 2030. A Latin American consensus

Málaga‐Figueroa, L., Alarcón, M. A., Pannuti, C. M., Valle, P. H., López‐Pacheco, A., Gómez, M., Jiménez, P., Romito, G. A., Lozano, E., Duque, A., et al. (2023) · Journal of Periodontal Research · doi:10.1111/jre.13221 · Cited by 3

Vaccination protects against acute respiratory distress syndrome (ARDS) in hospitalized patients with COVID-19

Madrid, J., Agarwal, P., Müller‐Peltzer, K., Askani, M., Benning, L., Selig, M., Diehl, P., Kalbhenn, J., Trummer, G., Utzolino, S., et al. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01293-w · Cited by 3

Production and evaluation of a bivalent adjuvant inactivated vaccine against infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus

Zhang, Z., Guan, C., Zhao, J., Lin, J., Shao, Y., Li, L., Lu, T., Peng, C., Zhang, Y., & Xu, L. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741914 · Cited by 3

New Waves of COVID-19 in Thailand, Cambodia and Myanmar

Cheepsattayakorn, A., Cheepsattayakorn, R., & Siriwanarangsun, P. (2021) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20210903.12 · Cited by 3

End-to-end SARS-CoV-2 transmission risks in sport: Current evidence and practical recommendations

Jones, B. L., Phillips, G., Valeriani, F., Edwards, T., Adams, E. R., Bonadonna, L., Copeland, R., Cross, M., Dalton, C., Hodgson, L., et al. (2021) · South African Journal of Sports Medicine · doi:10.17159/2078-516x/2021/v33i1a11210 · Cited by 3

SARS-CoV-2 and regular patient treatment – from the use of rapid antigen testing up to treatment specific precaution measures

Durner, J., Beikler, T., Watts, D. C., Becker, M., & Draenert, M. E. (2021) · Head & Face Medicine · doi:10.1186/s13005-021-00289-9 · Cited by 3

SARS-CoV-2 immunity and an overview of the COVID-19 vaccines

Marković, M. (2021) · Medicinski podmladak · doi:10.5937/mp72-33315 · Cited by 3

The impact of COVID-19 epidemic phase and changes in mean viral loads: implications for SARS-CoV-2 testing strategies

Buckley, C., Wang, C. Y. T., Chatfield, M. D., Bletchly, C., Harris, P. N. A., & Whiley, D. M. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115598 · Cited by 3

RT-PCR cycle threshold value in combination with visual scoring of chest computed tomography at hospital admission predicts outcome in COVID-19

Ingberg, E., Ahlstrand, E., Cajander, P., Löf, E., Sundqvist, M., Wegener, M., Lidén, M., & Cajander, S. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2035428 · Cited by 3

A computer modeling method to analyze rideshare data for the surveillance of novel strains of SARS-CoV-2

Safranek, C. W., & Scheinker, D. (2022) · Annals of Epidemiology · doi:10.1016/j.annepidem.2022.08.051 · Cited by 3

COVID-19 and dentistry – safety issues regarding doctor and patient situation in time of vaccine availability

Pietrzak, P., & Hanke, W. (2021) · Medycyna Pracy · doi:10.13075/mp.5893.01140 · Cited by 3

An outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections among hospital personnel with high mRNA vaccine uptake

Tene, Y., Levytskyi, K., Adler, A., Halutz, O., Paran, Y., Goldshmidt, H., Itzhaki‐Alfia, A., Halperin, T., Stepansky, S., Ben‐Ami, R., et al. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.412 · Cited by 3

Exploring the Role of Serology Testing to Strengthen Vaccination Initiatives and Policies for COVID-19 in Asia Pacific Countries and Territories: A Discussion Paper

Chotpitayasunondh, T., Fisher, D. A., Hsueh, P., Lee, P., Crespo, K. A. N., & Ruxrungtham, K. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2030024 · Cited by 3

Actions and attitudes on the immunized patients against SARS-CoV-2

Ramos, P. D. L., Botella, A. G., García‐Lledó, A., Gómez‐Pavón, J., del Castillo, J. M. G., Hernández‐Sampelayo, T., Delgado, M. C. M., Martín‐Sánchez, F. J., Martínez‐Sellés, M., Molero, J., et al. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/131.2021 · Cited by 3

Modelled Optimization of SARS-Cov-2 Vaccine Distribution: an Evaluation of Second Dose Deferral Spacing of 6, 12, and 24 weeksPreprint

Jurgens, G., & Lackner, K. S. (2021) · medRxiv · doi:10.1101/2021.02.28.21252638 · Cited by 3

Low Dose Regimens of BNT162b2 mRNA Vaccine Exceed SARS-Cov-2 Correlate of Protection Estimates for Symptomatic Infection, in those 19-55 Years of AgePreprint

Graham, J. (2021) · medRxiv · doi:10.1101/2021.03.06.21253058 · Cited by 2

Changes in mobility pre and post first SARS-CoV-2 vaccination: findings from a prospective community cohort study including GPS movement tracking in England and Wales (Virus Watch)Preprint

Nguyen, V. G., Liu, Y., Mumford, R., Flanagan, B., Patel, P., Braithwaite, I., Shrotri, M., Byrne, T., Beale, S., Aryee, A., et al. (2021) · medRxiv · doi:10.1101/2021.06.21.21259237 · Cited by 3

Transmissibility of COVID-19 among Vaccinated Individuals: A Rapid Literature Review - Update #1Preprint

Egunsola, O., Mastikhina, L., Dowsett, L. E., Farkas, B., Hofmeister, M., Saxinger, L. M., & Clement, F. M. (2021) · medRxiv · doi:10.1101/2021.06.29.21255526 · Cited by 4

High Frequencies of PD-1 + TIM3 + TIGIT + CTLA4 + Functionally Exhausted SARS-CoV-2-Specific CD4 + and CD8 + T Cells Associated with Severe Disease in Critically ill COVID-19 PatientsPreprint

Coulon, P.-G. A., Prakash, S., Dhanushkodi, N. R., Srivastava, R., Zayou, L., Tifrea, D. F., Edwards, R. A., Cesar, J. F., Schubl, S. D., Hsieh, L. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.30.478343 · Cited by 4

Vaccinating children against SARS-CoV-2 - parents' attitude

Rakoczy, K., Kaczor, J., Sołtyk, A., Mastalska, I., Saczko, M., & Kulbacka, J. (2025) · Archives de Pédiatrie · doi:10.1016/j.arcped.2025.05.012 · Cited by 2

A Macro-Level Association of Vaccination Rate with the Number of Confirmed COVID-19 Cases in the United States and Japan

Noda, H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127435 · Cited by 2

A joint Bayesian hierarchical model for estimating SARS-CoV-2 genomic and subgenomic RNA viral dynamics and seroconversion

Dong, T. Q., & Brown, E. R. (2023) · Biostatistics · doi:10.1093/biostatistics/kxad016 · Cited by 2

Number of initial symptoms of SARS-CoV-2 infection is associated with the risk of otological symptoms: a retrospective study

Wang, Q., Gu, H., Tao, Y., Zhao, Y., & Meng, Z. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08866-w · Cited by 2

Impact of Vaccination Status on Chest CT Findings and Disease Outcomes in COVID-19 Era: A Retrospective Study

Abdulqader, S. K., Ali, S. S. M., Fadhil, A. A., Akram, N. N., & Nori, W. (2024) · Coronaviruses · doi:10.2174/0126667975315612240425074611 · Cited by 2

The ratio between SARS-CoV-2 RNA viral load and culturable viral titre differs depending on the stage of infection: a case study of household transmission in an adult male

Porter, M. K., Winnett, A. V., Hao, L., Shelby, N., Reyes, J. A., Schlenker, N. W., Romano, A. E., Tognazzini, C., Feaster, M., Goh, Y.-Y., et al. (2025) · Access Microbiology · doi:10.1099/acmi.0.000732.v3 · Cited by 2

Covid-19: Free rapid testing may end once most adults are fully vaccinated

Torjesen, I. (2021) · BMJ · doi:10.1136/bmj.n1760 · Cited by 2

Is the COVID-19 Pandemic Over? The Current Status of Boosters, Immunosenescence, Long Haul COVID, and Systemic Complications

Ting, M., & Suzuki, J. B. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2020021 · Cited by 3

Vaccination against SARS-CoV-2 and its relationship with public interest in mental health: a study between 2020-2022 in Spain

Becerra‐García, J. A., Barbeito, S., Calvo, A., & Sánchez‐Gutiérrez, T. (2022) · Psychology Health & Medicine · doi:10.1080/13548506.2022.2159049 · Cited by 2

Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines

Akbar, S. M. F., Mahtab, M. A., & Khan, S. (2023) · Vaccines · doi:10.3390/vaccines11030615 · Cited by 2

COVID-19 vaccination: the reality after clinical trials

Ruiz‐Galiana, J., Cantón, R., Ramos, P. D. L., Botella, A. G., García‐Lledó, A., Gómez‐Pavón, J., del Castillo, J. M. G., Hernández‐Sampelayo, T., Delgado, M. C. M., Martín‐Sánchez, F. J., et al. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/035.2021 · Cited by 3

New Metrics for Assessing the State Performance in Combating the COVID‐19 Pandemic

Li, Y., Rice, M., Li, M., Du, C., Xin, X., Wang, Z., Shi, X., & Yang, C. P. (2021) · GeoHealth · doi:10.1029/2021gh000450 · Cited by 2

Update on Rapid Diagnostics for COVID-19: A Systematic Review

Dias, B. D. P., Gonçalves, R. L., Ferreira, C. S., Barbosa, C. C., Arrieta, O. A. P., dos Santos, S. M. S. A., Malta, W. C., Silva, M. A. E., Gomes, M. L. M. D., Guimarães, A. G., et al. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2020023 · Cited by 2

Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England

Clifford, S., Waight, P., Hackman, J., Hué, S., Gower, C., Kirsebom, F. C. M., Skarnes, C., Letley, L. H., Bernal, J. L., Andrews, N. J., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17995.1 · Cited by 2

Comparative Pharmacological Efficacy of COVID-19 Vaccines against the Variants of Concerns (VOCs) of SARS-CoV-2: Recent Clinical Studies on Booster Dose

Zhao, D., Wang, X., Liu, J., Chinnappa, A. U., Basavaraj, V., Sri, C. D., Nikolenko, V. N., Beeraka, N. M., Shivaprakash, P., & Fan, R. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230227115329 · Cited by 2

Humoral Immune Responses following COVID-19 Vaccinations among Adults in Tanzania

Bakari, M., Aboud, S., Kasubi, M. J., Mmbando, B. P., Ntinginya, N. E., Sichalwe, A. W., Ubuguyu, O., Magesa, A. S., Rutananukwa, N. L., Nyawale, H. A., et al. (2023) · Vaccines · doi:10.3390/vaccines12010022 · Cited by 2

Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual

Kernéis, S., Planas, D., Imbeaud, S., Staropoli, I., Puech, J., Robillard, N., Rodary, J., Bruel, T., Vieillard, T., Schwartz, O., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab369 · Cited by 2

App Raises Public Awareness of the Importance of COVID-19 VaccinationPreprint

Chew, P. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3798475 · Cited by 2

How skeptics could be convinced (not persuaded) to get vaccinated against COVID-19Preprint

Rebitschek, F. G., Ellermann, C., Jenny, M. A., Siegel, N. A., Spinner, C., & Wagner, G. G. (2021) · doi:10.31234/osf.io/f4nqt · Cited by 2

Agent-based simulations for protecting nursing homes with prevention and vaccination strategiesPreprint

Lasser, J., Zuber, J., Sorger, J., Klager, E., Kletečka-Pulker, M., Willschke, H., Stangl, K., Stadtmann, S., Haslinger, C., Klimek, P., et al. (2020) · arXiv (Cornell University) · doi:10.17605/osf.io/hyd4r · Cited by 2

COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary

Manuel, O. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.06.018 · Cited by 2

Community-Based Phenotypic Study of Safety, Tolerability, Reactogenicity and Immunogenicity of Emergency-Use-Authorized Vaccines Against COVID-19 and Viral Shedding Potential of Post-Vaccination Infections: Protocol for an Ambispective studyPreprint

Gabashvili, I. S. (2021) · medRxiv · doi:10.1101/2021.06.28.21256779 · Cited by 1

Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of BangladeshPreprint

Al‐Emran, H. M., Hasan, M. S., Setu, M. A. A., Rahman, M. S., Alam, A. R. U., Sarkar, S. L., Islam, M. T., Islam, M. R., Rahman, M. M., Islam, O. K., et al. (2021) · medRxiv · doi:10.1101/2021.08.09.21261778 · Cited by 2

Waning of SARS-CoV-2 booster viral-load reduction effectiveness

Levine-Tiefenbrun, M., Yelin, I., Alapi, H., Herzel, E., Kuint, J., Chodick, G., Gazit, S., Patalon, T., & Kishony, R. (2022) · Nature Communications · doi:10.1038/s41467-022-28936-y · Cited by 63

Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2

Levine-Tiefenbrun, M., Yelin, I., Alapi, H., Katz, R., Herzel, E., Kuint, J., Chodick, G., Gazit, S., Patalon, T., & Kishony, R. (2021) · Nature Medicine · doi:10.1038/s41591-021-01575-4 · Cited by 222

First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers

Coppeta, L., Balbi, O., Grattagliano, Z., Mina, G. G., Pietroiusti, A., Magrini, A., Bolcato, M., & Aurilio, M. T. (2021) · Vaccines · doi:10.3390/vaccines9060659 · Cited by 18

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel

Regev-Yochay, G., Amit, S., Bergwerk, M., Lipsitch, M., Leshem, E., Kahn, R., Lustig, Y., Cohen, C., Doolman, R., Ziv, A., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100150 · Cited by 111

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., Caspi, I., Levy, R., Leshchinsky, M., Ken Dror, S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01413-7 · Cited by 373